{"id":577411,"date":"2023-06-05T18:12:24","date_gmt":"2023-06-05T15:12:24","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/astrazenecas-tagrisso-slashes-death-risk-in-certain-post-surgery-lung-cancer-patients\/"},"modified":"2023-06-05T18:12:24","modified_gmt":"2023-06-05T15:12:24","slug":"astrazenecas-tagrisso-slashes-death-risk-in-certain-post-surgery-lung-cancer-patients","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/astrazenecas-tagrisso-slashes-death-risk-in-certain-post-surgery-lung-cancer-patients\/","title":{"rendered":"#AstraZeneca&#8217;s Tagrisso slashes death risk in certain post-surgery lung cancer patients"},"content":{"rendered":"<div>By Natalie Grover<\/p>\n<p>LONDON (Reuters) &#8211; AstraZeneca&#8217;s lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data showed.<\/p>\n<p>Tagrisso is already the crown jewel in the Anglo-Swedish drugmaker&#8217;s portfolio, raking in $5.4 billion last year.<\/p>\n<p>The drug has regulatory <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/download-scripts-themes-apps\/\" data-internallinksmanager029f6b8e52c=\"9\" title=\"Download Scripts &amp; Themes &amp; Apps\" target=\"_blank\" rel=\"noopener\">app<\/a>rovals across multiple geographies for certain patients with so-called non small cell lung cancer (NSCLC) who have a mutation of the EGFR gene.<\/p>\n<p>The latest data, presented at the American Society of Clinical Oncology (ASCO) meeting, establishes Tagrisso as the backbone treatment for EGFR-mutated lung cancer, said Susan Galbraith, executive VP of oncology R&amp;D at AstraZeneca in a statement.<\/p>\n<p>In a 682-patient trial called ADAURA, Tagrisso was evaluated against a placebo in earlier-stage EGFR-mutated NSCLC patients who had undergone surgery to remove their primary tumour.<\/p>\n<p>The majority of such patients eventually see their cancer return despite surgery and add-on chemotherapy.<\/p>\n<p>In the trial, Tagrisso or a placebo was given to patients to assess whether the AstraZeneca therapy could keep their cancer at bay.<\/p>\n<p>Data showed Tagrisso slashed the risk of death by 51% compared to placebo.<\/p>\n<p>&#8220;This is a pretty dramatic and remarkable improvement,&#8221; said Dave Fredrickson, executive vice president of oncology at AstraZeneca in an interview with Reuters.<\/p>\n<p>An estimated 88% of patients treated with Tagrisso were alive at five years compared to 78% on placebo, trial data also showed.<\/p>\n<p>Outside of chemotherapy, there are no drugs apart from Tagrisso that have shown to help patients with EGFR-mutated lung cancer live longer, Fredrickson highlighted, adding that there are probably a third of eligible patients who are not yet being prescribed Tagrisso.<\/p>\n<p>&#8220;We would hope that we would be able to use these data to be able to close that gap,&#8221; he said.<\/p>\n<p>AstraZeneca is also expecting to provide details on the impact of combining Tagrisso with chemotherapy in patients with advanced EGFR-mutated lung cancer later this year.<\/p>\n<p>(Reporting by Natalie Grover in London; Editing by Angus MacSwan)<\/p>\n<\/div>\n<blockquote><p><strong><span style=\"color: #ff6600;\">If you liked the article, do not forget to share it with your friends. Follow us on\u00a0<span style=\"color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMLG0nwswvr63Aw\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\">For forums sites go to <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/forum.buradabiliyorum.com\/\" target=\"_blank\" rel=\"noopener\">Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong>\n<\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/news\/\" data-internallinksmanager029f6b8e52c=\"2\" title=\"News\" target=\"_blank\" rel=\"noopener\">News<\/a> articles, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/news\/\" target=\"_blank\" rel=\"noopener\">News category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/www.aol.com\/news\/astrazenecas-tagrisso-slashes-death-risk-151224789.html\" target=\"_blank\" rel=\"noopener\">Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Natalie Grover LONDON (Reuters) &#8211; AstraZeneca&#8217;s lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data showed. Tagrisso is already the crown jewel in the Anglo-Swedish drugmaker&#8217;s portfolio, raking&#8230;<\/p>\n","protected":false},"author":1,"featured_media":577412,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/media.zenfs.com\/en\/reuters-finance.com\/265f8948bc3de78ddb0a4233af7498c4","fifu_image_alt":"","footnotes":""},"categories":[70897],"tags":[],"class_list":["post-577411","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/577411","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=577411"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/577411\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/577412"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=577411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=577411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=577411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}